These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 25316841)

  • 1. An acute flaccid paralysis surveillance-based serosurvey of poliovirus antibodies in Western Uttar Pradesh, India.
    Bahl S; Gary HE; Jafari H; Sarkar BK; Pathyarch SK; Sethi R; Deshpande J
    J Infect Dis; 2014 Nov; 210 Suppl 1(Suppl 1):S234-42. PubMed ID: 25316841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-sectional serologic assessment of immunity to poliovirus infection in high-risk areas of northern India.
    Bahl S; Estívariz CF; Sutter RW; Sarkar BK; Verma H; Jain V; Agrawal A; Rathee M; Shukla H; Pathyarch SK; Sethi R; Wannemuehler KA; Jafari H; Deshpande JM
    J Infect Dis; 2014 Nov; 210 Suppl 1():S243-51. PubMed ID: 25316842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing population immunity in a persistently high-risk area for wild poliovirus transmission in India: a serological study in Moradabad, Western Uttar Pradesh.
    Deshpande JM; Bahl S; Sarkar BK; Estívariz CF; Sharma S; Wolff C; Sethi R; Pathyarch SK; Jain V; Gary HE; Pallansch MA; Jafari H
    J Infect Dis; 2014 Nov; 210 Suppl 1(Suppl 1):S225-33. PubMed ID: 25316839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interrupting wild poliovirus transmission using oral poliovirus vaccine: environmental surveillance in high-risks area of India.
    Chowdhary R; Dhole TN
    J Med Virol; 2008 Aug; 80(8):1477-88. PubMed ID: 18551602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of poliovirus antibodies amongst children in Zaria, Northern Nigeria.
    Giwa FJ; Olayinka AT; Ogunshola FT
    Vaccine; 2012 Nov; 30(48):6759-65. PubMed ID: 23000220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for eradication of poliomyelitis--the Indian experience.
    Banerjee K; Sahu S; Sarkar S
    Indian J Public Health; 2000; 44(1):5-14. PubMed ID: 11439860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sero-survey of polio antibodies and quality of acute flaccid paralysis surveillance in Chongqing, China: A cross-sectional study.
    Xu J; Kuang S; Rong R; Zhang Y; Tang W; Wang Q
    Medicine (Baltimore); 2020 Jul; 99(31):e21298. PubMed ID: 32756110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine-derived poliovirus surveillance in China during 2001-2013: the potential challenge for maintaining polio free status.
    Wang HB; Luo HM; Li L; Fan CX; Hao LX; Ma C; Su QR; Yang H; Reilly KH; Wang HQ; Wen N
    BMC Infect Dis; 2017 Dec; 17(1):742. PubMed ID: 29197328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What needs to be done for polio eradication in India?
    Paul Y
    Vaccine; 2007 Aug; 25(35):6431-6. PubMed ID: 17646037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Forewarning of poliovirus outbreaks in the Horn of Africa: an assessment of acute flaccid paralysis surveillance and routine immunization systems in Kenya.
    Walker AT; Sodha S; Warren WC; Sergon K; Kiptoon S; Ogange J; Ahmeda AH; Eshetu M; Corkum M; Pillai S; Scobie H; Mdodo R; Tack DM; Halldin C; Appelgren K; Kretsinger K; Bensyl DM; Njeru I; Kolongei T; Muigai J; Ismail A; Okiror SO
    J Infect Dis; 2014 Nov; 210 Suppl 1(0 1):S85-90. PubMed ID: 25316880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the prevalence of antibody immunodeficiency in a polio endemic area in India.
    Mohanty MC; Deshpande JM
    Trans R Soc Trop Med Hyg; 2014 May; 108(5):258-63. PubMed ID: 24652773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Support for children identified with acute flaccid paralysis under the global polio eradication programme in Uttar Pradesh, India: a qualitative study.
    Yotsu RR; Abba K; Smith H; Das A
    BMC Public Health; 2012 Mar; 12():229. PubMed ID: 22439606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An epidemiological analysis of Acute Flaccid Paralysis (AFP) surveillance in Kenya, 2016 to 2018.
    Tesfaye B; Sowe A; Kisangau N; Ogange J; Ntoburi S; Nekar I; Muitherero C; Camara Y; Gathenji C; Langat D; Sergon K; Limo H; Nzunza R; Kiptoon S; Kareko D; Onuekwusi I
    BMC Infect Dis; 2020 Aug; 20(1):611. PubMed ID: 32811467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study.
    Grassly NC; Wenger J; Durrani S; Bahl S; Deshpande JM; Sutter RW; Heymann DL; Aylward RB
    Lancet; 2007 Apr; 369(9570):1356-1362. PubMed ID: 17448821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-sectional Serologic Assessment of Immunity to Poliovirus in Differential Risk Areas of India: India Seroprevalence Survey - 2014.
    Ahmad M; Bahl S; Kunwar A
    Indian Pediatr; 2016 Aug; 53 Suppl 1():S14-S19. PubMed ID: 27771634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population immunity to polioviruses among preschool children from four urban underserved low income communities, United States, 1997-2001.
    Prevots DR; Pascual FB; Angellili ML; Brayden R; Irigoyen M; Larussa P; Sawyer M; Baughman AL; Pallansch MA
    Pediatr Infect Dis J; 2004 Dec; 23(12):1130-6. PubMed ID: 15626951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OPV cannot eradicate polio from India: do we need any further evidence?
    Paul Y
    Vaccine; 2008 Apr; 26(17):2058-61. PubMed ID: 18378367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
    Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD
    Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum IgG and IgA levels in polio and non-polio acute flaccid paralysis cases in western Uttar Pradesh, India.
    Mohanty MC; Nalavade UP; Deshpande JM
    Indian Pediatr; 2015 Mar; 52(3):220-2. PubMed ID: 25848998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polio vaccination coverage and seroprevalence of poliovirus antibodies after the introduction of inactivated poliovirus vaccines for routine immunization in Japan.
    Satoh H; Tanaka-Taya K; Shimizu H; Goto A; Tanaka S; Nakano T; Hotta C; Okazaki T; Itamochi M; Ito M; Okamoto-Nakagawa R; Yamashita Y; Arai S; Okuno H; Morino S; Oishi K
    Vaccine; 2019 Mar; 37(14):1964-1971. PubMed ID: 30827736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.